Data: 9 May 2026

Funding & Grants

Research funding associated with RMSANZ member publications. Grants are classified into NHMRC, ARC, MRFF, Government, International, University, Foundation, and Other categories.

10,546
Grants (filtered)
15
Funded Researchers
1369
Funding Bodies
27
Years of Data
Funder Type Breakdown
International: 3,219 (30.5%)
Other: 2,785 (26.4%)
NHMRC: 1,550 (14.7%)
Foundation: 1,196 (11.3%)
University: 963 (9.1%)
ARC: 430 (4.1%)
Government (AU): 394 (3.7%)
MRFF: 9 (0.1%)
Grants by Year
2000200320062009201220152017202020232026035070010501400
Funder Type Distribution
Top 10 Funding Bodies (Filtered)
#FunderGrantsShare
1National Health and Medical Research Council1,55014.7%
2National Institutes of Health7937.5%
3Australian Research Council4254.0%
4Medical Research Council3813.6%
5National Institute of Mental Health1701.6%
6National Institute on Aging1371.3%
7Wellcome Trust1331.3%
8National Heart Foundation of Australia1261.2%
9National Institute on Deafness and Other Communication Disorders1101.0%
10National Medical Research Council1071.0%
Most Funded Researchers (Filtered)
Recent Grants

Factors associated with long-term functional outcomes and participation in patients with colorectal cancers

Bhasker Amatya · Peter MacCallum Cancer Centre · 2026

Other

Implementing Reablement Programs for People Living With Dementia: A Scoping Review of Barriers, Facilitators and Strategies

Christopher Poulos · Dementia Centre for Research Collaboration · 2026

Other

Implementing Reablement Programs for People Living With Dementia: A Scoping Review of Barriers, Facilitators and Strategies

Christopher Poulos · Australian Research Council · 2026

ARC

Developing a national strategy to support implementation of reablement for community-dwelling people living with dementia

Christopher Poulos · Australian Research Council · 2026(FL190100011)

ARC

From QI-disability to QID-12: creating a brief proxy-report measure of quality of life for children with intellectual disability

Dr Dinah Susan Reddihough · University of Western Australia · 2026

University

Safety and efficacy of intensive task-specific training in people with recent spinal cord injury: a phase 3, pragmatic, randomised, assessor-blinded, superiority trial

Dr Emma-Leigh Synnott · Wings for Life · 2026

Other

Safety and efficacy of intensive task-specific training in people with recent spinal cord injury: a phase 3, pragmatic, randomised, assessor-blinded, superiority trial

Dr Emma-Leigh Synnott · NSW Ministry of Health · 2026

Other

Safety and efficacy of intensive task-specific training in people with recent spinal cord injury: a phase 3, pragmatic, randomised, assessor-blinded, superiority trial

Dr Emma-Leigh Synnott · Faculty of Medicine and Health, University of Sydney · 2026

University

EPIC-ND: a multi-site, randomised controlled trial evaluating the effectiveness of social prescribing for the unmet social needs of children with a neurodisability and their parent/carers – a study protocol

Dr Heather Anne Burnett · Cerebral Palsy Alliance Research Foundation · 2026(PRG00619)

Foundation

Safety and efficacy of intensive task-specific training in people with recent spinal cord injury: a phase 3, pragmatic, randomised, assessor-blinded, superiority trial

Dr Jasbeer Kaur · Wings for Life · 2026

Other

Safety and efficacy of intensive task-specific training in people with recent spinal cord injury: a phase 3, pragmatic, randomised, assessor-blinded, superiority trial

Dr Jasbeer Kaur · NSW Ministry of Health · 2026

Other

Safety and efficacy of intensive task-specific training in people with recent spinal cord injury: a phase 3, pragmatic, randomised, assessor-blinded, superiority trial

Dr Jasbeer Kaur · Faculty of Medicine and Health, University of Sydney · 2026

University

[177Lu]Lu-PSMA-617 in combination with pembrolizumab for treatment of metastatic castration resistant prostate cancer (PRINCE): a single-arm, phase 1b/2 study

Dr Jon Ho Chan · Victorian Cancer Agency · 2026

Other

[177Lu]Lu-PSMA-617 in combination with pembrolizumab for treatment of metastatic castration resistant prostate cancer (PRINCE): a single-arm, phase 1b/2 study

Dr Jon Ho Chan · Endocyte · 2026

Other

[177Lu]Lu-PSMA-617 in combination with pembrolizumab for treatment of metastatic castration resistant prostate cancer (PRINCE): a single-arm, phase 1b/2 study

Dr Jon Ho Chan · MSD Australia · 2026

Other

Vision Intervention for Seeing Impaired Babies: Learning through Enrichment (VISIBLE) – protocol of a feasibility pilot randomised controlled trial

Dr Margot Louise Bosanquet · Ministero della Salute · 2026(RC-2024-2025)

Other

Vision Intervention for Seeing Impaired Babies: Learning through Enrichment (VISIBLE) – protocol of a feasibility pilot randomised controlled trial

Dr Margot Louise Bosanquet · Cerebral Palsy Alliance Research Foundation · 2026(PG15717)

Foundation

Genetics of cannabis ever-use and frequency across ancestries implicate novel loci and brain-specific biology

Dr Martin John Kennedy · University of Bristol · 2026(MC_UU_00011/7)

University

Genetics of cannabis ever-use and frequency across ancestries implicate novel loci and brain-specific biology

Dr Martin John Kennedy · Nierstichting · 2026(19OS004)

Other

Genetics of cannabis ever-use and frequency across ancestries implicate novel loci and brain-specific biology

Dr Martin John Kennedy · National Health and Medical Research Council · 2026(2034568)

NHMRC